GLSWQ (Gelesis Holdings) Days Payable : 1,553.54 (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Gelesis Holdings Days Payable?

Gelesis Holdings's average Accounts Payable for the three months ended in Jun. 2023 was $8.48 Mil. Gelesis Holdings's Cost of Goods Sold for the three months ended in Jun. 2023 was $0.50 Mil. Hence, Gelesis Holdings's Days Payable for the three months ended in Jun. 2023 was 1,553.54.

The historical rank and industry rank for Gelesis Holdings's Days Payable or its related term are showing as below:

GLSWQ' s Days Payable Range Over the Past 10 Years
Min: 94.02 Med: 231.03 Max: 368.03
Current: 190.72

During the past 2 years, Gelesis Holdings's highest Days Payable was 368.03. The lowest was 94.02. And the median was 231.03.

GLSWQ's Days Payable is not ranked
in the Biotechnology industry.
Industry Median: 134.39 vs GLSWQ: 190.72

Gelesis Holdings's Days Payable increased from Jun. 2022 (337.24) to Jun. 2023 (1,553.54). It may suggest that Gelesis Holdings delayed paying its suppliers.

Gelesis Holdings Days Payable Historical Data

The historical data trend for Gelesis Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gelesis Holdings Days Payable Chart

Gelesis Holdings Annual Data

Trend

Dec21

Dec22

Days Payable

368.03

94.02

Gelesis Holdings Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Payable	Get a 7-Day Free Trial					337.24	379.84	38.76	443.93	1,553.54

Competitive Comparison of Gelesis Holdings's Days Payable

For the Biotechnology subindustry, Gelesis Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelesis Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gelesis Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Gelesis Holdings's Days Payable falls into.

Gelesis Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Gelesis Holdings's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (10.066	+	4.131)	/	2 )	/	27.558	*	365
=	7.0985					/	27.558	*	365
=	94.02

Gelesis Holdings's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Mar. 2023 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (7.905	+	9.052)	/	2 )	/	0.498	*	365 / 4
=	8.4785					/	0.498	*	365 / 4
=	1,553.54

Gelesis Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Gelesis Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Gelesis Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gelesis Holdings Inc (OTCPK:GLSWQ) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

501 Boylston Street, Suite 6102, Boston, MA, USA, 02116

Website

https://www.gelesis.com

Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic diseases. Its portfolio includes Plenity, an FDA-cleared product to aid in weight management, as well as potential therapies in development for patients with Type 2 Diabetes, Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH), and Functional Constipation.